Schedule III is half official. On April 22, Acting AG Todd Blanche signed a thirty-four-page order rescheduling FDA-approved marijuana and state medical cannabis under treaty authority. The rest of cannabis gets a six-week hearing in Arlington. The industry is toasting a meal that was never served. What AG Order 6754-2026 actually did, what it didn't, and what cannabis testing labs should be doing this week before federal scrutiny arrives with a return address.

Trump didn’t legalize cannabis. He revived a stalled rescheduling process and took the victory lap. Schedule III changes the optics, not the fundamentals; and it puts laboratories and operators on a collision course with federal scrutiny they’re not prepared for.